Migraine study: Multimodal Treatment Program
Official title Multimodal Physiotherapy Intervention for People With Migraine
ClinicalTrials.gov ID: NCT07671703
What this study is testing
- What it's testing
- This study aims to find out if a specific mix of physical therapy, education, and exercise works better than usual physical therapy for managing migraine symptoms.
- Who it's for
- Adults aged 18 to 60 who have a confirmed diagnosis of migraine.
- What's involved
- Participants will receive either a new program that includes physical therapy, education about migraine, moderate aerobic exercise, and relaxation techniques, or standard physical therapy.
- Time commitment
- The treatment lasts for three months, and participants will keep a diary of their headaches and complete surveys to track their progress.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Aged 18-70 years.
- Have a diagnosis of migraine established by a headache specialist according to the International Classification of Headache Disorders, 3rd edition...
- Have experienced migraine symptoms for more than 3 months, with headaches occurring on at least 2 days per month.
- Provide written informed consent before participation.
- Complete a study-specific self-assessment questionnaire based on the ICHD-3 criteria to confirm the migraine diagnosis and classify participants as...
You likely can't join if
- Other primary or secondary headache disorders.
- Acute neurological diseases or abnormal neurological examination findings.
- Rheumatic diseases, vascular diseases, cancer, or other serious medical conditions.
- Comorbid chronic pain disorders (e.g., fibromyalgia).
- Diagnosed psychiatric disorders (e.g., major depression or schizophrenia).
- Substance abuse.
See the full eligibility criteria
- Aged 18-70 years.
- Have a diagnosis of migraine established by a headache specialist according to the International Classification of Headache Disorders, 3rd edition (ICHD-3).
- Have experienced migraine symptoms for more than 3 months, with headaches occurring on at least 2 days per month.
- Provide written informed consent before participation.
- Complete a study-specific self-assessment questionnaire based on the ICHD-3 criteria to confirm the migraine diagnosis and classify participants as having episodic or chronic migraine.
- Other primary or secondary headache disorders.
- Acute neurological diseases or abnormal neurological examination findings.
- Rheumatic diseases, vascular diseases, cancer, or other serious medical conditions.
- Comorbid chronic pain disorders (e.g., fibromyalgia).
- Diagnosed psychiatric disorders (e.g., major depression or schizophrenia).
- Substance abuse.
- Physiotherapy for headache or neck pain within 3 months before study enrolment.
- Previous surgery involving the jaw, cervical spine, or head.
- Pregnancy.
- Pain not clearly attributable to migraine.
- Inability or unwillingness to provide informed consent.
- There are no restrictions regarding sex, ethnicity, or country of residence.
The study team makes the final eligibility decision.
Where it is enrolling
- Osnabrück, Low Saxony, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Osnabrück, Low Saxony, Germany. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.